DNAI7
Dynein axonemal intermediate chain 7
Also known as: CASC1, CFAP94, DNAI7_HUMAN, FLJ10921, LAS1, PPP1R54
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q6TDU7
- Gene
- DNAI7
- Ensembl
- ENSG00000118307
- Chromosome
- 12
- Canonical length
- 716 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Vesicles,Cytosol
OverviewNCBI Gene
Predicted to enable beta-tubulin binding activity and microtubule binding activity. Predicted to be located in cilium and microtubule cytoskeleton. Predicted to be part of axonemal dynein complex. Predicted to be active in axoneme and cytoplasmic microtubule. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
716 residues, UniProt reviewed canonical sequence.
>Q6TDU7|DNAI7
1 MSGSKKKKVT KAERLKLLQE EEERRLKEEE EARLKYEKEE MERLEIQRIE KEKWHRLEAK
61 DLERRNEELE ELYLLERCFP EAEKLKQETK LLSQWKHYIQ CDGSPDPSVA QEMNTFISLW
121 KEKTNETFEE VIEKSKVVLN LIEKLKFILL ETPPCDLQDK NIIQYQESIL QLQELLHLKF
181 GVATEILLKQ ASTLADLDSG NMEKVIKDEN VTLYVWANLK KNPRHRSVRF SETQIGFEIP
241 RILATSDIAV RLLHTHYDHV SALHPVSTPS KEYTSAVTEL VKDDVKNVEK AISKEVEEES
301 KQQERGSHLI QEEEIKVEEE QGDIEVKMSS AEEESEAIKC EREMKVLSET VSAAQLLLVE
361 NSSEKPDFFE DNVVDLCQFT TLGGVYHLDI LELPPQCKPV KGWMIVEILK EGLQKYTYPP
421 ETTEEFETEN AFPPIEVTLE VHENVIFFED PVVVRWDAEG KHWRTDGISN VSYKPKERLV
481 TFSLDTFGPV TLIQDAHINM PYQSWELRPL DVNKVLLTVT TVFTEIQIQI KENLCMLSSI
541 KLKDKKHISI LEGTWMTPIP FIIALKEAGL NIFPTRHSHF YVIINNKVPL VEVKAYRQMA
601 LLSSAFAFGW SKWNLLCNST KVVFKVREHL TEACTENPNW ALLMFSGDRA QRLKIKEESE
661 AFSEALKEET EFHSTLYHMV KDFASEEAME KVRSSNCQFV NSVCHMLLST RLLSYSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against DNAI7 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.3
- Highest tissue expression
- 21 nTPM
Expression across tissuesHPA
Tissue
- testis: 21 nTPM
- choroid plexus: 14 nTPM
- fallopian tube: 13 nTPM
- epididymis: 5.6 nTPM
- retina: 4.7 nTPM
- pituitary gland: 4.1 nTPM
Single-cell type
- ependymal cells: 589 nCPM
- respiratory ciliated cells: 504 nCPM
- early spermatids: 373 nCPM
- choroid plexus epithelial cells: 356 nCPM
- fallopian tube ciliated cells: 349 nCPM
- late primary spermatocytes: 316 nCPM
Immune cell
- neutrophil: 1.4 nTPM
- naive B-cell: 1 nTPM
- memory B-cell: 0.7 nTPM
- basophil: 0.4 nTPM
- NK-cell: 0.4 nTPM
- plasmacytoid DC: 0.4 nTPM
Brain region
- choroid plexus: 31 nTPM
- medulla oblongata: 18 nTPM
- midbrain: 18 nTPM
- spinal cord: 14 nTPM
- hypothalamus: 11 nTPM
- pons: 9.9 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.96
- gnomAD pLI
- 0
- DepMap mean gene effect
- -0.03
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- CASC1, C-terminal
- Dynein-f, intermediate chain IC97/Dnai7-like
- IC97/Casc1, N-terminal
- Cancer susceptibility candidate 1 C-terminal
- Cancer susceptibility candidate 1 N-terminus
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads DNAI7 as an antibody target. Whether an autoantibody or antibody against DNAI7 could matter depends on whether native DNAI7 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
DNAI7 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label DNAI7 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...